Xenon Pharmaceuticals Inc.
Pharmaceutical Preparations·BURNABY·FY end 12/31·CIK 1582313
CEO Pay Ratio
37:1
Ian Mortimer
CEO Total Comp
$9.2M
Ian Mortimer
Median Employee
$246,438
Revenue
—
FY 2025
Net Income
-$345.9M
FY 2025
Free Cash Flow
-$279.9M
FY 2025
Net Margin
—
Insider Net (180d)
-$20.8M
0 buys / 21 sales
CEO Pay Accountability
CEO comp as % of net income
-2.67%
For every $1,000 of profit, $-26.66 flows to the CEO.
CEO comp as % of buybacks
—
No buyback data for the most recent fiscal year.